ArticleMolecular oncology2023

HORMAD1 overexpression predicts response to anthracycline-cyclophosphamide and survival in triple-negative breast cancers.

Rania El-Botty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.